Topiramate - NDC Database (Page 24)
68788-8835 Feb 21, 2025
Topiramate 100 mg Oral Tablet, Film Coated by Preferred Pharmaceuticals Inc.
Topiramate 100 mg Oral Tablet, Film Coated by Preferred Pharmaceuticals Inc.
68788-8967 Jan 11, 2016
Topiramate 100 mg Oral Tablet, Film Coated by Preferred Pharmaceuticals Inc.
Topiramate 100 mg Oral Tablet, Film Coated by Preferred Pharmaceuticals Inc.
68788-9499 Mar 14, 2014
Topiramate 25 mg/1 Oral Tablet, Film Coated by Preferred Pharmaceuticals, Inc.
Topiramate 25 mg/1 Oral Tablet, Film Coated by Preferred Pharmaceuticals, Inc.
68788-9533 Dec 18, 2013
Topiramate 50 mg/1 Oral Tablet, Film Coated by Preferred Pharmacetucals, Inc.
Topiramate 50 mg/1 Oral Tablet, Film Coated by Preferred Pharmacetucals, Inc.
69680-177 Apr 07, 2025
Topiramate 25 mg Oral Capsule, Extended Release by Vitruvias Therapeutics, Inc.
Topiramate 25 mg Oral Capsule, Extended Release by Vitruvias Therapeutics, Inc.
69680-178 Apr 07, 2025
Topiramate 50 mg Oral Capsule, Extended Release by Vitruvias Therapeutics, Inc.
Topiramate 50 mg Oral Capsule, Extended Release by Vitruvias Therapeutics, Inc.
69680-179 Apr 07, 2025
Topiramate 100 mg Oral Capsule, Extended Release by Vitruvias Therapeutics, Inc.
Topiramate 100 mg Oral Capsule, Extended Release by Vitruvias Therapeutics, Inc.
69680-180 Apr 07, 2025
Topiramate 150 mg Oral Capsule, Extended Release by Vitruvias Therapeutics, Inc.
Topiramate 150 mg Oral Capsule, Extended Release by Vitruvias Therapeutics, Inc.
69680-181 Apr 07, 2025
Topiramate 200 mg Oral Capsule, Extended Release by Vitruvias Therapeutics, Inc.
Topiramate 200 mg Oral Capsule, Extended Release by Vitruvias Therapeutics, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.